Telesta Therapeutics Inc. (BNC)

[BioSpecialist]

THE RUNUP HAS JUST BEGUN !!!! get in now before its too late .this stock is a lifetime opportunity .

Bioniche life science (BNC.TO) . Market cap of 80 mil$ is a big joke ..

Positive Phase 3 results coming next month .Urocidin for bladder cancer is a real Blockbuster (1-2 Billion Dollars Potential) .

Positive results will trigger a big milestone payment for Bioniche .

In 2009, Bioniche licensed Urocidin’s U.S. commercial rights to Endo Pharmaceuticals . Based on incidence of bladder cancer and possible pricing, he figures the global market opportunity for Urocidin in the refractory population could be $800 million. If the second Phase 3 trial expands the Urocidin label to first-line treatment, the market opportunity could grow to an estimated $2 billion.


HUGE BREAKOUT IS COMING ...
http://3.bp.blogspot.com/_4f_p2K3hwOo/THHOw07Y25I/AAAAAAAAKBA/jj2FGUf0ybE/s1600/bnc.png" rel="nofollow" target="_blank" >http://3.bp.blogspot.com/_4f_p2K3hwOo/THHOw07Y25I/AAAAAAAAKBA/jj2FGUf0ybE/s1600/bnc.png

http://www.barchart.com/cheatsheet.php?sym=BNC.TO" rel="nofollow" target="_blank" >http://www.barchart.com/cheatsheet.php?sym=BNC.TO